Healthy high growth potential

Results

1496

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1496 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MDGL
US$509.760.8%70.2%US$11.8bUS$678.7110.459.2%n/aPharmaceuticals & Biotech
NVDA
US$199.00-5.5%28.4%US$4.8tUS$298.9330.221.8%0.5%Semiconductors
LITE
US$842.53-0.9%789.6%US$65.5bUS$1,111.29149.379.1%n/aTech
CRDO
US$268.99-1.0%183.0%US$50.2bUS$269.81106.227.5%n/aSemiconductors
COXG
€12.151.3%23.5%€1.0b€15.3515.024.7%n/aUtilities
RHM
€949.00-18.9%-45.4%€44.5b€1,868.1042.130.7%1.2%Capital Goods
KEBNI B
SEK 1.22-5.8%-39.5%SEK 334.3mSEK 1.602.982.7%n/aTech
FWRY
ج.م19.000.5%50.2%ج.م64.7bج.م21.2424.328.7%n/aDiversified Financials
CORT
US$81.56-0.2%10.2%US$8.6bUS$88.00187.648.9%n/aPharmaceuticals & Biotech
AGP
€7.131.6%-5.8%€130.0m€8.5726.237.8%n/aCapital Goods
AXSM
US$237.92-5.6%129.4%US$12.5bUS$276.4717.357.4%n/aPharmaceuticals & Biotech
MOD
US$276.70-2.5%170.4%US$14.7bUS$340.86120.349.3%n/aCapital Goods
688192
CN¥39.052.9%-34.6%CN¥18.5bCN¥91.3820.3105.8%n/aPharmaceuticals & Biotech
2455
NT$390.00-6.3%202.3%NT$73.4bNT$398.50123.145.2%0.7%Semiconductors
9218
JP¥705.000.7%6.0%JP¥7.4bn/a31.128.9%1.4%Healthcare
7769
NT$6,910.00-0.9%427.5%NT$1.2tNT$9,322.7186.243.7%0.9%Semiconductors
456A
JP¥1,535.00-8.2%n/aJP¥136.4bn/a43.423.4%n/aRetail
7685
JP¥3,480.00-2.4%151.4%JP¥221.0bJP¥4,666.6729.225.5%0.6%Retail
2368
NT$1,240.00-8.5%360.1%NT$634.2bNT$1,485.0055.338.2%0.8%Tech
A458870
₩33,050.000.8%316.6%₩1.3t₩69,000.0041.341.5%n/aHealthcare
002810
CN¥25.166.2%114.9%CN¥9.0bCN¥36.0043.643.1%1.6%Materials
PNI
AU$16.94-1.1%-14.3%AU$4.0bAU$22.1331.621.1%3.3%Diversified Financials
CDR
zł226.000.6%-17.9%zł22.6bzł234.5643.726.9%0.4%Media
688700
CN¥93.00-8.3%146.6%CN¥27.4bCN¥53.67186.957.4%0.2%Capital Goods
Page 1 of 42